ARTICLE | Company News
Biosynexus, QVT Fund LP deal
June 20, 2005 7:00 AM UTC
Biosynexus disclosed that it was acquired on May 26 by QVT Fund. Terms of the deal were not disclosed. Also, Biosynexus' BSYX-A110 has completed Phase II trials to prevent staphylococcal infection in...